Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Amortization of Deferred Charges (2018 - 2025)

Historic Amortization of Deferred Charges for Bio Key International (BKYI) over the last 10 years, with Q3 2025 value amounting to $60000.0.

  • Bio Key International's Amortization of Deferred Charges rose 2275.21% to $60000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $226947.0, marking a year-over-year increase of 3028.93%. This contributed to the annual value of $175900.0 for FY2024, which is 269.07% up from last year.
  • As of Q3 2025, Bio Key International's Amortization of Deferred Charges stood at $60000.0, which was up 2275.21% from $60000.0 recorded in Q2 2025.
  • In the past 5 years, Bio Key International's Amortization of Deferred Charges registered a high of $60000.0 during Q1 2025, and its lowest value of $22074.0 during Q3 2022.
  • Its 5-year average for Amortization of Deferred Charges is $39184.0, with a median of $38665.0 in 2024.
  • In the last 5 years, Bio Key International's Amortization of Deferred Charges plummeted by 9751.25% in 2021 and then surged by 10540.0% in 2023.
  • Quarter analysis of 5 years shows Bio Key International's Amortization of Deferred Charges stood at $32204.0 in 2021, then decreased by 17.39% to $26605.0 in 2022, then surged by 70.02% to $45234.0 in 2023, then grew by 3.79% to $46947.0 in 2024, then grew by 27.8% to $60000.0 in 2025.
  • Its last three reported values are $60000.0 in Q3 2025, $60000.0 for Q2 2025, and $60000.0 during Q1 2025.